Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
miRNA–mRNA Control of JH in Insect Vitellogenesis
2026-09-28
Li and colleagues identify coordinated miRNA–mRNA regulation as a mechanism that supports juvenile hormone biosynthesis during vitellogenesis in the migratory locust. Their expression, reporter, and perturbation results connect miRNA repression of biosynthetic genes with vitellogenin expression and ovarian development, while leaving open how juvenile hormone levels themselves change after manipulation.
-
CpAdhE Inhibition and Imidazole Activity in C. parvum
2026-09-27
A 2024 study identified the bacterial-type bifunctional enzyme CpAdhE as a biochemical target for inhibitor discovery in Cryptosporidium parvum and found lower-micromolar inhibition by several antifungal imidazoles. Three imidazoles also reduced parasite growth in vitro, providing a rationale for further target validation—not evidence of clinical efficacy or a proven mechanism in parasite cells.
-
Podocyte Exosomal HMGB1 in Lupus Nephritis
2026-09-26
A 2025 study links podocyte-derived exosomes carrying HMGB1 to glomerular endothelial cell injury in lupus nephritis, with TRIM27 identified as a downstream mediator. The combined patient, cell, and mouse evidence supports a podocyte-to-endothelial signaling pathway and offers experimental strategies for testing its contribution to renal injury.
-
Decoding mRNA Delivery Beyond Uptake
2026-09-25
A dual-fluorescence reporter can help translational researchers separate mRNA uptake from productive expression. Learn how to design more informative delivery assays and interpret them in light of recent polymer-micelle findings.
-
Isradipine (Dynacirc): Assay Design Guide
2026-09-25
This scenario-based guide explains how to use Isradipine (Dynacirc), SKU A8453, in cell viability, proliferation, and calcium-signaling workflows without confusing channel modulation with cell death. It covers stock preparation, controls, neuronal-model limitations, and practical criteria for evaluating product quality.
-
H 89 2HCl: PKA Assay Workflows
2026-09-24
Use H 89 2HCl to test whether cellular responses depend on PKA, while separating pathway inhibition from changes in cAMP itself. This workflow connects dopamine-regulated osteoclast differentiation to practical controls for phosphorylation, CREB activity, and cell health.
-
Pazopanib Beyond Target Inhibition: Assay Logic
2026-09-24
Pazopanib (GW-786034) offers a way to interrogate several receptor tyrosine kinase signals at once. This article explains how to distinguish target engagement, cellular response, and ATRX-associated sensitivity when designing cancer research assays.
-
N6-Methyl-dATP: From Polymerase Mechanism to AML Context
2026-09-23
N6-Methyl-dATP offers a controlled biochemical probe for testing how adenine modification affects nucleotide recognition and DNA synthesis. This article connects assay design to AML transcriptional biology while distinguishing a useful mechanistic bridge from evidence the literature has not yet established.
-
Cy5 Hydrazide for Carbonyl Labeling Workflows
2026-09-23
Cy5 hydrazide enables far-red labeling of protein carbonyls, oxidized glycoproteins, and aldehyde-bearing oligonucleotides for sensitive gel and imaging workflows. Its non-sulfonated format offers strong optical output, but requires disciplined DMSO handling and controls when applied to FAST nutraceutical nanoparticles.
-
Pazopanib Hydrochloride: From Kinase Map to Translation
2026-09-22
Pazopanib Hydrochloride, also known as GW786034, is more than an anti-angiogenic agent: it is a translational probe for studying how coordinated receptor tyrosine kinase blockade reshapes tumor, endothelial, and stromal biology. This article connects its multi-target mechanism with improved in vitro response metrics and strategic model selection for renal cell carcinoma and soft tissue sarcoma research.
-
hiPSC Intestinal Organoids for Pharmacokinetic Studies
2026-09-22
Saito and colleagues developed an accessible direct 3D culture strategy for generating expandable intestinal organoids from human induced pluripotent stem cells. The resulting organoid-derived epithelial cells retained differentiated intestinal lineages and displayed drug-metabolizing enzyme and transporter activities, supporting more human-relevant absorption and pharmacokinetic studies.
-
hiPSC Intestinal Organoids for Pharmacokinetic Studies
2026-09-21
Saito and colleagues established a direct three-dimensional cluster-culture strategy for generating expandable intestinal organoids from human induced pluripotent stem cells. The organoids could be propagated, cryopreserved, and differentiated into intestinal epithelial cells with enterocyte-associated metabolic and transporter activities, supporting more human-relevant pharmacokinetic studies.
-
Pazopanib (GW-786034) in ATRX Glioma Assays
2026-09-21
Pazopanib (GW-786034) provides a practical multi-targeted RTK probe for connecting ATRX status with receptor signaling, glioma viability, and combination responses. This guide translates the reference study into reproducible dose-response, pathway, angiogenesis, and tumor growth suppression workflows while emphasizing controls and troubleshooting.
-
Cy3 TSA Fluorescence System Kit for Receptor Mapping
2026-09-20
The Cy3 TSA Fluorescence System Kit connects ultrasensitive fluorescence imaging with modern receptor biology. This guide explains how tyramide chemistry can support spatial validation of low-abundance targets while preserving the mechanistic insights gained from cryo-EM studies of class II olfactory receptors.
-
FLOT1–FOSL2–EphA2 Axis in Alzheimer’s Disease
2026-09-19
A 2026 Neuropharmacology study identifies a FLOT1–FOSL2–EphA2 regulatory pathway that links microglial polarization with p38/MAPK signaling and neuroinflammation in an APP/PS1 model. Its integrated molecular, cellular, and behavioral evidence suggests that FLOT1 suppression can reduce pro-inflammatory microglial responses and improve spatial memory, while also highlighting important limits for translation to human Alzheimer’s disease.